Which Is a Better Investment, The Chemours Company or Hawkins, Inc. Stock?

view original post

Featured Tickers:

Sifting through countless of stocks in the Chemicals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in The Chemours Company, Hawkins or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how The Chemours Company, Hawkins and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About The Chemours Company, Hawkins and Inc.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. The company sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Hawkins, Inc. operates as a water treatment and specialty ingredients company in the United States. The company operates through three segments: Water Treatment, Industrial, and Health and Nutrition. The Water Treatment segment provides chemicals, products, equipment, services, and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agriculture water. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade and pharmaceutical products, such as liquid phosphates, lactates, other blended products, and agricultural products; and receives, stores, and distributes various chemicals comprising liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. This segment offers minerals, vitamins and amino acids, excipients, joint products, botanicals and herbs, sweeteners, and enzymes. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.

Latest Chemicals and The Chemours Company, Hawkins, Inc. Stock News

As of January 8, 2026, The Chemours Company had a $2.1 billion market capitalization, compared to the Chemicals median of $3.3 million. The Chemours Company’s stock is up 21.3% in 2026, up 16.7% in the previous five trading days and down 18.19% in the past year.

Currently, The Chemours Company does not have a price-earnings ratio. The Chemours Company’s trailing 12-month revenue is $5.8 billion with a -5.5% net profit margin. Year-over-year quarterly sales growth most recently was -0.9%. Analysts expect adjusted earnings to reach $0.967 per share for the current fiscal year. The Chemours Company currently has a 2.5% dividend yield.

As of January 8, 2026, Hawkins, Inc. had a $3.2 billion market cap, putting it in the 62nd percentile of all stocks. Hawkins, Inc.’s stock is up 11% in 2026, up 8.5% in the previous five trading days and up 28.86% in the past year.

Currently, Hawkins, Inc.’s price-earnings ratio is 38.7. Hawkins, Inc.’s trailing 12-month revenue is $1.0 billion with a 8.0% net profit margin. Year-over-year quarterly sales growth most recently was 13.5%. Analysts expect adjusted earnings to reach $3.985 per share for the current fiscal year. Hawkins, Inc. currently has a 0.5% dividend yield.

How We Compare The Chemours Company, Hawkins and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at The Chemours Company, Hawkins and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions